Special Aspects of Renal Osteodystrophy in Children

Seminars in Nephrology

Volumn 24, Issue 1, 2004, Pages 69-77

  Salusky, Isidro B ^a   Kuizon, Beatriz G ^b   Jüppner, Harald ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

BONE DEFORMATION; BONE GROWTH; BONE REMODELING; BONE TURNOVER; CARTILAGE; CHILD; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; ENCHONDRAL OSSIFICATION; GROWTH PLATE; GROWTH RETARDATION; HUMAN; KIDNEY FAILURE; MALNUTRITION; METABOLIC ACIDOSIS; NONHUMAN; OSTEODYSTROPHY; PATHOGENESIS; PRIORITY JOURNAL; RAT; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

EID: 0942290523     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnephrol.2003.08.009     Document Type: Article

References (71)

1. Salusky IB, Goodman WG: Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy. Kidney Int 48:657-665, 1995
2. Goodman WG, Coburn JW, Slatopolsky E, et al: Renal osteodystrophy in adults and children, in Favus MJ (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 347-363
3. Furth SL, Hwang W, Yang C, et al: Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 17:450-455, 2002
4. McSherry E, Morris RC: Attainment and maintenance of normal status with alkali therapy in infants and children with classic renal tubular acidosis (RTA). J Clin Invest 61:509-527, 1978
5. Challa A, Chan W, Krieg RJ, et al: Effect of metabolic-acidosis on the expression of insulin-like growth-factor and growth-hormone receptor. Kidney Int 44:1224-1227, 1993
6. Kuemmerle N, Krieg RJ, Latta K, et al: Growth hormone and insulin-like growth factor in non-uremic acidosis and uremic acidosis. Kidney Int 58:S102-S105, 1997
7. Maniar S, Kleinknecht C, Zhou X, et al: Growth hormone action is blunted by acidosis in experimental uremia or acid load. Clin Nephrol 46:72-76, 1996
8. 3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol. JAMA 234:47-52, 1975
9. 3 in childhood renal osteodystrophy. N Engl J Med 298:238-242, 1978
10. Langman CB, Mazur AT, Baron R, et al: 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: Beneficial effect on linear growth velocity. J Pediatr 100:815-820, 1982
11. Chan JCM, McEnery PT, Chinchilli VM, et al: A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. J Pediatr 124:520-528, 1994
12. Hodson EM, Evans RA, Dunstan CR, et al: Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol. Clin Nephrol 24:192-200, 1985
13. Salusky IB, Fine RN, Kangarloo H, et al: "High-dose" calcitriol for control of renal osteodystrophy in children on CAPD. Kidney Int 32:89-95, 1987
14. Goodman WG, Salusky IB: Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 90:189-195, 1991
15. Salusky IB, Coburn JW, Brill J, et al: Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982, 1988
16. Mathias RS, Salusky IB, Harmon WH, et al: Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children's hospital. J Am Soc Nephrol 12:1938-1946, 1993
17. Cohen-Solal ME, Sebert JL, Boudailliez B, et al: Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516-524, 1991
18. Salusky IB, Ramirez JA, Oppenheim WL, et al: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258, 1994
19. Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 43:436-442, 1993
20. Quarles LD, Lobaugh B, Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150, 1992
21. Salusky IB, Kuizon BD, Belin T, et al: Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration. Kidney Int 54:907-914, 1998
22. Hodson EM, Evans RA, Dunstan CR, et al: Quantitative bone histology in children with chronic renal failure. Kidney Int 21:833-839, 1982
23. Hsu AC, Kooh SW, Fraser D, et al: Renal osteodystrophy in children with chronic renal failure: An unexpectedly common and incapacitating complication. Pediatrics 70:742-750, 1982
24. Norman ME, Mazur AT, Borden S, et al: Early diagnosis of juvenile renal osteodystrophy. J Pediatr 97:226-232, 1980
25. 3]. Histologic bone studies. Acta Pediatr Scand 73:315-324, 1984
26. Goodman WG, Salusky IB, Jüppner H: Parathyroid hormone (PTH), its receptors, and the biological relevance of PTH-derived peptides. Nephrol Dial Transplant 17:1-6, 2002
27. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1987
28. Andress DL, Norris KC, Coburn JW, et al: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
29. Goodman WG, Ramirez JA, Belin TR, et al: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
30. Klaus G, Mehls O, Hinderer J, et al: Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? Lancet 337:800-801, 1991
31. Martin KJ, Bullal HS, Domoto DT, et al: Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: Preliminary observations. Am J Kidney Dis 19:540-545, 1992
32. Slatopolsky E, Weerts C, Thielan J, et al: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
33. Gonzalez EA, Martin KJ: Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells. Kidney Int 50:63-70, 1996
34. 3: Humoral and histomorphometric results. Miner Electrolyte Metab 12:375-382, 1986
35. Brossard JH, Cloutier M, Roy L, et al: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923-3929, 1996
36. Lepage R, Roy L, Brossard JH, et al: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809, 1998
37. Coen G, Bonucci E, Ballanti P, et al: PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348-354, 2002
38. Salusky IB, Goodman WG, Kuizon BD, et al: Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801-1808, 2003
39. 3 on renal function, mineral balance, and growth in children with severe chronic renal failure. Pediatrics 68:559-571, 1981
40. Kuizon BD, Goodman WG, Jüppner H, et al: Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure. Kidney Int 53:205-211, 1998
41. Schmitt CP, Ardissino G, Testa S, et al: Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440-444. 2003
42. D'Amour P, Huet PM: Ca2+ concentration influences the hepatic extraction of bioactive human PTH-(1-34) in rats. Am J Physiol 256:E87-E92, 1989
43. Sanchez CP, Kuizon BD, Abdella PA, et al: Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536-1544, 2000
44. Sanchez CP, Salusky IB, Kuizon BD, et al: Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887, 1998
45. Saggese G, Federico G, Cinquanta L: In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr 391:54-59, 1993 (suppl)
46. 3 differentially regulates the production of insulin-like growth factor-I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146, 1991
47. Colston KW, Perks CM, Xie SP, et al: Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 20:157-162, 1998
48. Nickerson T, Huynh H: Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins. J Endocrinol 160:223-229, 1999
49. Longobardi L, Torello M, Buckway C, et al: A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology 144:1695-1702, 2003
50. Haffner D, Schaefer F, Nissel R, et al: Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 343:923-930, 2000
51. Tonshoff B, Cronin MJ, Reichert M, et al: and the European Study Group for Nutritional Treatment of Chronic Renal failure in Childhood, Members of the German Study Group for Growth Hormone Treatment in Chronic Renal Failure: Reduced concentration of serum growth hormone (GH)binding protein in children with chronic renal failure: Correlation with GH insensitivity. J Clin Endocrinol Metab 82:1007-1013, 1997
52. Schaefer F, Chen Y, Tsao T, et al: Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108:467-475, 2001
53. Tonshoff B, Eden S, Weiser E, et al: Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 45:1085-1092, 1994
54. Wuhl E, Haffner D, Nissel R, et al: and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 10:294-298, 1996
55. Lanske B, Karaplis AC, Lee K, et al: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666, 1996
56. Lee K, Vortkamp A, Tabin C, et al: Indian hedgehog delays the differentiation of growth-plate chondrocytes by stimulating expression of PTHrP. J Bone Miner Res 11:125, 1996
57. Vortkamp A, Lee K, Lanske B, et al: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622, 1996
58. Karaplis AC, Luz A, Glowacki J, et al: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289, 1994
59. Mehls O, Krempien B, Ritz E, et al: Renal osteodystrophy in children on maintenance hemodialysis. Proc EDTA 10:197-201, 1973
60. Chattopadhyay N, Baum M, Bai M, et al: Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 271:F736-F743, 1996
61. Adler Y, Herz I, Vaturi M, et al: Mitral annular calcium detected by transthoracic echocardiography is a marker for high prevalence and severity of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 82:1183-1186, 1998
62. Hanna JD, Santos F, Foreman JW, et al: Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 47:1374-1382, 1995
63. Ureña P, Ferreira A, Morieux C, et al: PTH/PTHrP receptor mRNA is downregulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 11:2008-2016, 1996
64. Cobo A, Carbajo E, Santos F, et al: Morphometry of uremic rat growth plate. Miner Electrolyte Metab 22:192-195, 1996
65. Mehls O, Ritz E, Hunziker EB, et al: Improvement of growth and food utilization by recombinant human growth hormone in uremia. Kidney Int 33:45-52, 1988
66. Cobo A, Lopez JM, Carbajo E, et al: Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10:971-979, 1999
67. Vu TH, Shipley JM, Bergers G, et al: MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422, 1998
68. Ureña P, Kubrusly M, Mannstadt M, et al: The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605-611, 1994
69. Ureña P, Mannstadt M, Hruby M, et al: Parathyroidectomy does not prevent the renal PTH/PTHrP receptor downregulation in uremic rats. Kidney Int 47:1797-1805, 1995
70. Langub MC, Monier-Faugere MC, Qi QL, et al: Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor in human bone. J Bone Miner Res 16:448-456, 2001
71. DeVita MV, Rasenas LL, Bansal M, et al: Assessment of renal osteodystrophy in hemodialysis patients. Medicine (Baltimore) 71:284-290, 1992